Literature DB >> 33766266

Comparative Study of Oral Anticoagulation in Left Ventricular Thrombi (No-LVT Trial).

Mahmoud Abdelnabi, Yehia Saleh, Ahmed Fareed, Alexander Nossikof, Ling Wang, Mahmoud Morsi, Nouran Eshak, Ola Abdelkarim, Haitham Badran, Abdallah Almaghraby.   

Abstract

Entities:  

Year:  2021        PMID： 33766266     DOI： 10.1016/j.jacc.2021.01.049

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  8 in total

1.  Unexplained arterial thrombosis: approach to diagnosis and treatment.

Authors:  Jori E May; Stephan Moll
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

2.  Direct Oral Anticoagulants Versus Vitamin K Antagonists in the Treatment of Left Ventricular Thrombi.

Authors:  Yehia Saleh; Abdullah Al-Abcha; Ola Abdelkarim; Mahmoud Abdelnabi; Abdallah Almaghraby; Neal S Kleiman
Journal:  Am J Cardiovasc Drugs       Date:  2021-11-05       Impact factor: 3.571

3.  Warfarin versus direct oral anticoagulants for treating left ventricular thrombus: a systematic review and meta-analysis.

Authors:  Tarun Dalia; Shubham Lahan; Sagar Ranka; Amandeep Goyal; Sara Zoubek; Kamal Gupta; Zubair Shah
Journal:  Thromb J       Date:  2021-02-01

Review 4.  Direct Oral Anticoagulants vs Vitamin K Antagonists in Left Ventricular Thrombi: A Systematic Review and Meta-analysis.

Authors:  Faith Michael; Navneet Natt; Mohammed Shurrab
Journal:  CJC Open       Date:  2021-05-06

Review 5.  Switching from warfarin to direct-acting oral anticoagulants: it is time to move forward!

Authors:  Mahmoud Abdelnabi; Juthipong Benjanuwattra; Osama Okasha; Abdallah Almaghraby; Yehia Saleh; Fady Gerges
Journal:  Egypt Heart J       Date:  2022-03-28

6.  Direct Oral Anticoagulants Versus Vitamin K Antagonists for the Treatment of Left Ventricular Thrombus: An Updated Meta-Analysis of Cohort Studies and Randomized Controlled Trials.

Authors:  Yanming Chen; Mei Zhu; Kai Wang; Qiang Xu; Jing Ma
Journal:  J Cardiovasc Pharmacol       Date:  2022-06-01       Impact factor: 3.271

7.  Rivaroxaban for Treatment of Left Ventricular Thrombus: A Case Report.

Authors:  Juhaina Salim Al-Maqbali; Maitha Al-Sibani; Nasiba Al-Maqrashi; Abdullah M Al Alawi; Hatim Al Lawati
Journal:  Am J Case Rep       Date:  2021-06-25

Review 8.  Ventricular non-compaction review.

Authors:  Shaurya Srivastava; Majid Yavari; Abdullah Al-Abcha; Sandeep Banga; George Abela
Journal:  Heart Fail Rev       Date:  2021-07-07       Impact factor: 4.654
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.